Certara Inc (CERT) is a Healthcare · Health Information Services company listed on NASDAQ. Price $8.29 (-3.38%), Market cap $0.71B, 52-week low–high $4.48 ~ $13.60.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intell
Financial statements, price targets, institutional (13F) holdings and related news for Certara Inc are updated in real time on BlackAll Trade.
Certara Inc trades at $8.29 (-3.38%). Real-time quotes and charts are available on BlackAll Trade.
Certara Inc has a market cap of about $0.71B.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions,